Tokorozawa, Japan

Manabu Kaneda

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manabu Kaneda. Retrieved from https://idiyas.com/inventor/manabu-kaneda-rgp2iaaz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,570 
Other
 patents

Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Manabu Kaneda: Innovator in Bicyclolactam Compounds

Introduction

Manabu Kaneda is a notable inventor based in Tokorozawa, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on bicyclolactam compounds. His research focuses on developing compounds that exhibit anxiolytic effects while minimizing side effects.

Latest Patents

Kaneda holds a patent for "Bicycloloactam compounds, use thereof and intermediates for preparing thereof." This patent describes a bicyclolactam compound that demonstrates an excellent anxiolytic effect and is considered safe for use in medicinal applications. The compound is particularly valuable due to its reduced side effects, such as those associated with hypnotics, muscle relaxants, and sedatives. He has 1 patent to his name.

Career Highlights

Throughout his career, Kaneda has focused on the synthesis and application of novel chemical compounds. His work has contributed to advancements in the development of safer medications, enhancing the quality of life for patients requiring anxiolytic treatments.

Collaborations

Kaneda has collaborated with esteemed colleagues, including Nobuo Kasahara and Kazuo Ogawa. Their combined expertise has fostered a productive research environment, leading to innovative discoveries in the field.

Conclusion

Manabu Kaneda's contributions to the field of medicinal chemistry, particularly through his work on bicyclolactam compounds, highlight his commitment to improving patient safety and treatment efficacy. His innovative spirit continues to inspire advancements in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…